Mental Health, Medical Illness, and Treatment with a Focus on Depression and Anxiety

Encyclopedia of Mental Health: Second Edition

Volumn , Issue , 2016, Pages 107-118

  Ironson, G ^a   Fitch, C ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Anxiety; Cancer; CHD; Comorbidity; Depression; Diabetes; HIV; Medical illness; Mental health; Prevalence; Progression; Treatment

Indexed keywords

EID: 84985865012     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397045-9.00135-X     Document Type: Chapter

References (124)

1. Ali S., Stone M., Peters J., Davies M., Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: A systematic review and meta-analysis. Diabetic Medicine 2006, 23(11):1165-1173.
2. Andersen B.L., Yang H., Farrar W.B., et al. Psychologic intervention improves survival for breast cancer patients. Cancer 2008, 113(12):3450-3458 10.1002/cncr.23969.
3. Anderson R.J., Groot M.D., Grigsby A.B., et al. Anxiety and poor glycemic control: A meta-analytic review of the literature. International Journal of Psychiatry in Medicine 2002, 32(3):235-247.
4. Antoni M.H., Carrico A.W., Durán R.E., et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosomatic Medicine 2006, 68(1):143-151.
5. Antoni M.H., Cruess S., Cruess D.G., et al. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Annals of Behavioral Medicine 2000, 22(1):29-37.
6. Antoni M.H., Lehman J.M., Kilbourn K.M., et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychology 2001, 20(1):20-32 10.1037/0278-6133.20.1.20.
7. Barth J., Schumacher M., Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosomatic Medicine 2004, 66(6):802-813.
8. Baumeister H., Hutter N., Bengel J., Härter M. Quality of life in medically ill persons with comorbid mental disorders: A systematic review and meta-analysis. Psychotherapy and Psychosomatics 2011, 80(5):275-286.
9. Berecki-Gisolf J., McKenzie S.J., Dobson A.J., McFarlane A., McLaughlin D. A history of comorbid depression and anxiety predicts new onset of heart disease. Journal of Behavioral Medicine 2013, 36(4):347-353.
10. Berkman L.F., Blumenthal J., Burg M., et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. JAMA: Journal of the American Medical Association 2003, 289(23):3106-3116.
11. Bing E.G., Burnam M.A., Longshore D., et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry 2001, 58(8):721.
12. Black P.H. The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain, Behavior, and Immunity 2003, 17(5):350-364.
13. Blumenthal J.A., Babyak M.A., O'Connor C., et al. Effects of exercise training on depressive symptoms in patients with chronic heart failure. The HF-ACTION randomized Trial. Exercise, depressive symptoms, and heart failure. JAMA 2012, 308(5):465-474.
14. Boesen E.H., Boesen S.H., Frederiksen K., et al. Survival after a psychoeducational intervention for patients with cutaneous malignant melanoma: A replication study. Journal of Clinical Oncology 2007, 25(36):5698-5703 10.1200/JCO.2007.10.8894.
15. Brewer T.H., Zhao W., Metsch L.R., Coltes A., Zenilman J. High-risk behaviors in women who use crack: Knowledge of HIV serostatus and risk behavior. Annals of Epidemiology 2007, 17(7):533-539.
16. Brintzenhofe-Szoc K.M., Levin Tomer T., Li Y., Kissane D.W., Zabora J.R. Mixed Anxiety/Depression symptoms in a large cancer cohort: Prevalence by cancer type. Psychosomatics 2009, 50(4):383-391.
17. Burack J.H., Barrett D.C., Stall R.D., et al. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA: The Journal of the American Medical Association 1993, 270(21):2568-2573.
18. Carney R., Freedland K. Treatment-resistant depression and mortality after acute coronary syndrome. American Journal of Psychiatry 2009, 166(4):410-417.
19. Carrico A.W., Riley E.D., Johnson M.O., et al. Psychiatric risk factors for HIV disease progression: The role of inconsistent patterns of anti-retroviral therapy utilization. Journal of Acquired Immune Deficiency Syndromes (1999) 2011, 56(2):146-150.
20. Carvajal S.C., Estrada A.L., Estrada B.D., Jones-Rodriguez G. Determinants of HIV risk and protective needle-sharing behaviors among drug injectors. Journal of Applied Biobehavioral Research 2011, 16(2):98-120 10.1111/j.1751-9861.2011.00067.x.
21. CDC, 2011. HIV Surveillance Report, vol. 23. Available at: (accessed 20.12.14). http://www.cdc.gov/hiv/library/reports/surveillance/#special.
22. Chida Y., Hamer M., Steptoe A., Wardle J. Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nature Clinical Practice Oncology 2008, 5:466-475.
23. Chida Y., Steptoe A. The association of anger and hostility with future coronary heart disease: A meta-analytic review of prospective evidence. Journal of the American College of Cardiology 2009, 53(11):936-946.
24. Collins M., Corcoran P., Perry I. Anxiety and depression symptoms in patients with diabetes. Diabetic Medicine 2009, 26(2):153-161.
25. Cook J.A., Grey D., Burke J., et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Journal Information 2004, 94(7):1133-1140.
26. Crump C., Sundquist K., Winkleby M.A., Sundquist J. Comorbidities and mortality in bipolar Disorder: A swedish national cohort study. JAMA Psychiatry 2013, E1-E9 10.1001/jamapsychiatry.2013.1394.
27. Cunningham A.J., Edmonds C.V.I., Jenkins G.P., et al. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psycho-Oncology 1998, 7(6):508-517.
28. Davidson K.W., Mostofsky E. Anger expression and risk of coronary heart disease: Evidence from the Nova Scotia Health Survey. American Heart Journal 2010, 159(2):199-206. Available at: http://dx.doi.org/10.1016/j.ahj.2009.11.007 (accessed 03.09.14).
29. Denollet J., Rombouts H., Gillebert T., et al. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996, 347(8999):417-421.
30. Druss B.G., Zhao L., Von Esenwein S., Morrato E.H., Marcus S.C. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Medical Care 2011, 49(6):599-604.
31. Duijts S.F.A., Zeegers M.P.A., Borne B.V. The association between stressful life events and breast cancer risk: A meta-analysis. International Journal of Cancer 2003, 107(6):1023-1029 10.1002/ijc.11504.
32. Dusseldorp E., van Elderen T., Maes S., Meulman J., Kraaij V. A meta-analysis of psychoeducational programs for coronary heart disease patients. Health Psychology 1999, 18(5):506-519.
33. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. Journal of Psychosomatic Research 2007, 62(1):31-38.
34. Evans D.L., Charney D.S., Lewis L., et al. Mood disorders in the medically ill: Scientific review and recommendations. Biological Psychiatry 2005, 58(3):175-189. Available at: http://dx.doi.org/10.1016/j.biopsych.2005.05.001 (accessed 03.09.14).
35. Fawzy F.I., Fawzy N.W., Hyun C.S., et al. Malignant melanoma: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Archives of General Psychiatry 1993, 50(9):681-689 10.1001/archpsyc.1993.01820210015002.
36. Ferrando S.J., Freyberg Z. Treatment of depression in HIV positive individuals: A critical review. International Review of Psychiatry 2008, 20(1):61-71.
37. Figueroa-Moseley C., Jean-Pierre P., Roscoe J.A., et al. Behavioral interventions in treating anticipatory nausea and vomiting. Journal of the National Comprehensive Cancer Network 2007, 5(1):44-50.
38. Forrest D.W., Metsch L.R., LaLota M., Cardenas G., Beck D.W., Jeanty Y. Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. Journal of Urban Health 2010, 87(3):480-485.
39. Frasure-Smith N., Lespérance F., Talajic M. Depression following myocardial infarction. JAMA: The Journal of the American Medical Association 1993, 270(15):1819-1825.
40. Fuller-Thomson E., Brennenstuhl S. Making a link between childhood physical abuse and cancer. Cancer 2009, 115(14):3341-3350 10.1002/cncr.24372.
41. Gallo J.J., Bogner H.R., Morales K.H., et al. The effect of a primary care practice-based depression intervention on mortality in older adults. Annals of Internal Medicine 2007, 146(10):689-698. -W164.
42. Giese-Davis J., Collie K., Rancourt K.M.S., et al. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: A secondary analysis. Journal of Clinical Oncology 2011, 29(4):413-420 10.1200/JCO.2010.28.4455.
43. Giese-Davis J., Sephton S.E., Abercrombie H.C., Duŕn R.E.F., Spiegel D. Repression and high anxiety are associated with aberrant diurnal cortisol rhythms in women with metastatic breast cancer. Health Psychology 2004, 23(6):645-650 10.1037/0278-6133.23.6.645.
44. Glassman A.H., Bigger J.T., Gaffney M. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: Seven-year follow-up of SADHART participants. Archives of General Psychiatry 2009, 66(9):1022-1029.
45. Glassman A.H., O'Connor C.M., Califf R.M., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA: The Journal of the American Medical Association 2002, 288(6):701-709.
46. Golden S.H. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Current Diabetes Reviews 2007, 3(4):252-259.
47. Golden S.H., Lazo M., Carnethon M., et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA: The Journal of the American Medical Association 2008, 299(23):2751-2759.
48. Gonzalez J.S., Batchelder A.W., Psaros C., Safren S.A. Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. JAIDS: Journal of Acquired Immune Deficiency Syndromes 2011, 58(2):181-187.
49. Gonzalez J.S., Fisher L., Polonsky W.H. Depression in diabetes: Have we been missing something important?. Diabetes Care 2011, 34(1):236-239.
50. Gonzalez J.S., Peyrot M., McCarl L.A., et al. Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care 2008, 31(12):2398-2403.
51. Goodwin P.J., Leszcz M., Ennis M., et al. The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine 2001, 345(24):1719-1726.
52. Grigsby A.B., Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J. Prevalence of anxiety in adults with diabetes: A systematic review. Journal of Psychosomatic Research 2002, 53(6):1053-1060. Available at: http://dx.doi.org/10.1016/S0022-3999(02)00417-8 (accessed 03.09.14).
53. Honig A., Kuyper A.M., Schene A.H., et al. Treatment of post-myocardial infarction depressive disorder: A randomized, placebo-controlled trial with mirtazapine. Psychosomatic medicine 2007, 69(7):606-613.
54. Ickovics J.R., Hamburger M.E., Vlahov D., et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA: The Journal of the American Medical Association 2001, 285(11):1466-1474.
55. Ironson G., Hayward H. Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence. Psychosomatic Medicine 2008, 70(5):546-554.
56. Ironson G., O'Cleirigh C., Fletcher M.A., et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosomatic Medicine 2005, 67(6):1013-1021 10.1097/01.psy.0000188569.58998.c8.
57. Janeway D. An integrated approach to the diagnosis and treatment of anxiety within the practice of cardiology. Cardiology in Review 2009, 17(1):36-43.
58. Katon W.J., Lin E.H., Von Korff M., et al. Collaborative care for patients with depression and chronic illnesses. New England Journal of Medicine 2010, 363(27):2611-2620.
59. Kelly C.M., Juurlink D.N., Gomes T., et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: A population based cohort study. BMJ: British Medical Journal 2010, 340-348.
60. Kemppainen J.K., MacKain S., Reyes D. Anxiety symptoms in HIV-infected individuals. Journal of the Association of Nurses in AIDS Care 2013, 24(1):S29-S39.
61. Kessler R.C., Chiu W.T., Demler O., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005, 62(6):617-627.
62. Kissane D.W., Grabsch B., Clarke D.M., et al. Supportive-expressive group therapy for women with metastatic breast cancer: Survival and psychosocial outcome from a randomized controlled trial. Psycho-Oncology 2007, 16(4):277-286 10.1002/pon.1185.
63. Latkin C.A., Mandell W. Depression as an antecedent of frequency of intravenous drug use in an urban, nontreatment sample. Substance Use & Misuse 1993, 28(14):1601-1612.
64. Lawrence D., Hancock K.J., Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: Retrospective analysis of population based registers. British Medical Journal 2013, 346 10.1136/bmj.f2539.
65. Lelutiu-Weinberger C., Pachankis J.E., Golub S.A., et al. Age cohort differences in the effects of gay-related stigma, anxiety and identification with the gay community on sexual risk and substance use. AIDS and Behavior 2013, 17(1):340-349.
66. Leserman J., Barroso J., Pence B.W., Salahuddin N., Harmon J.L. Trauma, stressful life events and depression predict HIV-related fatigue. AIDS Care 2008, 20(10):1258-1265.
67. Lespérance F., Frasure-Smith N., Talajic M., Bourassa M.G. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002, 105(9):1049-1053.
68. Lillberg K., Verkasalo P.K., Kaprio J., et al. Stressful life events and risk of breast cancer in 10,808 women: A cohort study. American Journal of Epidemiology 2003, 157(5):415-423 10.1093/aje/kwg002.
69. Linden W., Phillips M.J., Leclerc J. Psychological treatment of cardiac patients: A meta-analysis. European Heart Journal 2007, 28(24):2972-2984.
70. Machtinger E., Wilson T., Haberer J., Weiss D. Psychological trauma and PTSD in HIV-positive women: A meta-analysis. AIDS and Behavior 2012, 16(8):2091-2100.
71. Markowitz J.C., Kocsis J.H., Fishman B., et al. Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Archives of General Psychiatry 1998, 55(5):452-457.
72. Markowitz S.M., Gonzalez J.S., Wilkinson J.L., Safren S.A. A review of treating depression in diabetes: Emerging findings. Psychosomatics 2011, 52(1):1-18.
73. Mezuk B., Eaton W.W., Albrecht S., Golden S.H. Depression and type 2 diabetes over the lifespan a meta-analysis. Diabetes Care 2008, 31(12):2383-2390.
74. Mimiaga M.J., Noonan E., Donnell D., et al. Childhood sexual abuse is highly associated with HIV risk-taking behavior and infection among MSM in the EXPLORE study. Journal of Acquired Immune Deficiency Syndromes (1999) 2009, 51(3):340-348.
75. Mitchell A.J., Chan M., Bhatti H., et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncology 2011, 12(2):160-174. Available at: http://iiiprxy.library.miami.edu:4357/10.1016/S1470-2045(11)70002-X (accessed 30.9.14).
76. Mitchell A.J., Rao S., Vaze A. International comparison of clinicians' ability to identify depression in primary care: Meta-analysis and meta-regression of predictors. British Journal of General Practice 2011, 61(583):e72-e80.
77. Mols F., Denollet J. Type D personality in the general population: A systematic review of health status, mechanisms of disease, and work-related problems. Health and Quality of Life Outcomes 2010, 8(9).
78. Moser D.K., McKinley S., Riegel B., et al. Relationship of persistent symptoms of anxiety to morbidity and mortality outcomes in patients with coronary heart disease. Psychosomatic Medicine 2011, 73(9):803-809 10.1097/PSY.0b013e3182364992.
79. Mugavero M.J., Pence B.W., Whetten K., et al. Predictors of AIDS-related morbidity and mortality in a southern US cohort. AIDS Patient Care and STDs 2007, 21(9):681-690.
80. Musselman D.L., Betan E., Larsen H., Phillips L.S. Relationship of depression to diabetes types 1 and 2: Epidemiology, biology, and treatment. Biological Psychiatry 2003, 54(3):317-329.
81. Mustanski B. The influence of state and trait affect on HIV risk behaviors: A daily diary study of MSM. Health Psychology 2007, 26(5):618-626.
82. Naaman S., Radwan K., Fergusson D., Johnson S. Status of psychological trials in breast cancer patients: A report of three meta-analyses. Psychiatry 2009, 72(1):50-69.
83. Nel A., Kagee A. The relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in south africa. AIDS Care 2013, 25(8):948-955 10.1080/09540121.2012.748867.
84. Nouwen A., Winkley K., Twisk J., et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: A systematic review and meta-analysis. Diabetologia 2010, 53(12):2480-2486.
85. Olatunji B.O., Mimiaga M.J., O Cleirigh C., Safren S.A. A review of treatment studies of depression in HIV. Topics in HIV Medicine 2006, 14(3):112-124.
86. Orth-Gomér K., Schneiderman N., Wang H., et al. Stress reduction prolongs life in women with coronary disease the stockholm Women's intervention trial for coronary heart disease (SWITCHD). Circulation: Cardiovascular Quality and Outcomes 2009, 2(1):25-32.
87. O'Cleirigh C., Skeer M., Mayer K.H., Safren S.A. Functional impairment and health care utilization among HIV-infected men who have sex with men: The relationship with depression and post-traumatic stress. Journal of behavioral medicine 2009, 32(5):466-477.
88. O'Cleirigh C., Traeger L., Mayer K.H., Magidson J.F., Safren S.A. Anxiety specific pathways to HIV sexual transmission risk behavior among young gay and bisexual men. Journal of Gay & Lesbian Mental Health 2012, 17(3):314-326.
89. Paile-Hyvärinen M., Wahlbeck K., Eriksson J.G. Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: A double-blind randomised placebo controlled 6-month trial. BMC Family Practice 2007, 8(1):34-41.
90. Parhami I., Fong T.W., Siani A., Carlotti C., Khanlou H. Documentation of psychiatric disorders and related factors in a large sample population of HIV-positive patients in California. AIDS and Behavior 2013, 17(8):2792-2801.
91. Parker G., Hyett M., Hadzi-Pavlovic D., Brotchie H., Walsh W. GAD is good? generalized anxiety disorder predicts a superior five-year outcome following an acute coronary syndrome. Psychiatry Research 2011, 188(3):383-389. doi:http://dx.doi.org/10.1016/j.psychres.2011.05.018.
92. Penninx B.W.J.H., Guralnik J.M., Havlik R.J., et al. Chronically depressed mood and cancer risk in older persons. Journal of the National Cancer Institute 1998, 90(24):1888-1893 10.1093/jnci/90.24.1888.
93. Petrak F., Herpertz S. Treatment of depression in diabetes: An update. Current Opinion in Psychiatry 2009, 22(2):211-217.
94. Pilowsky D.J., Wu L., Burchett B., Blazer D.G., Ling W. Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: Results from the clinical trials network. Substance Use & Misuse 2011, 46(14):1716-1725.
95. Pinquart M., Duberstein P.R. Depression and cancer mortality: A meta-analysis. Psychological Medicine 2010, 40(11):1797-1810. Available at: http://dx.doi.org/10.1017/S0033291709992285 (accessed 30.09.14).
96. Pressman S.D., Cohen S. Does positive affect influence health?. Psychological Bulletin 2005, 131(6):925-971.
97. Renn B.N., Feliciano L., Segal D.L. The bidirectional relationship of depression and diabetes: A systematic review. Clinical Psychology Review 2011, 31(8):1239-1246.
98. Roest A.M., Martens E.J., de Jonge P., Denollet J. Anxiety and risk of incident coronary heart DiseaseA meta-analysis. Journal of the American College of Cardiology 2010, 56(1):38-46.
99. Roscoe J., Morrow G., Aapro M., Molassiotis A., Olver I. Anticipatory nausea and vomiting. Supportive Care in Cancer 2011, 19(10):1533-1538 10.1007/s00520-010-0980-0.
100. Rugulies R. Depression as a predictor for coronary heart disease: A review and meta-analysis. American Journal of Preventive Medicine 2002, 23(1):51-61. Available at: http://dx.doi.org/10.1016/S0749-3797(02)00439-7 (accessed 30.09.14).
101. Rustad J.K., Musselman D.L., Nemeroff C.B. The relationship of depression and diabetes: Pathophysiological and treatment implications. Psychoneuroendocrinology 2011, 36(9):1276-1286.
102. Safren S.A., O'Cleirigh C.M., Bullis J.R., et al. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial. Journal of Consulting and Clinical Psychology 2012, 80(3):404-415.
103. Safren S.A., O'Cleirigh C., Tan J.Y., et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology 2009, 28(1):1-10.
104. Schneiderman N., Antoni M.H., Penedo F.J., Ironson G.H. Psychosocial-Behavioral interventions and chronic disease. Handbook of Behavioral Medicine 2010, 989-1007. Springer, New York, NY. A. Steptoe (Ed.).
105. Schneiderman N., Saab P.G., Catellier D.J., et al. Psychosocial treatment within sex by ethnicity subgroups in the enhancing recovery in coronary heart disease clinical trial. Psychosomatic Medicine 2004, 66(4):475-483.
106. Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. Journal of the National Cancer Institute 2000, 92(12):994-1000 10.1093/jnci/92.12.994.
107. Simoni J.M., Safren S.A., Manhart L.E., et al. Challenges in addressing depression in HIV research: Assessment, cultural context, and methods. AIDS and Behavior 2011, 15(2):376-388.
108. Spiegel D., Butler L.D., Giese-Davis J., et al. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer. Cancer 2007, 110(5):1130-1138 10.1002/cncr.22890.
109. Spiegel D., Giese-Davis J. Depression and cancer: Mechanisms and disease progression. Biological Psychiatry 2003, 54(3):269-282. Available at: http://iiiprxy.library.miami.edu:4357/10.1016/S0006-3223(03)00566-3 (accessed 30.09.14).
110. Spiegel D., Kraemer H., Bloom J., Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989, 334(8668):888-891. Available at: http://iiiprxy.library.miami.edu:4357/10.1016/S0140-6736(89)91551-1 (accessed 30.09.14).
111. Strik J.J., Honig A., Lousberg R., et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: Findings from a double-blind, placebo-controlled trial. Psychosomatic Medicine 2000, 62(6):783-789.
112. Temoshok, L., Heller, B., 1981. Stress and 'Type C' versus epidemiological risk factors in melanoma. Paper presented at the 89th Annual Convention of the American Psychological Association, Los Angeles, CA.
113. Temoshok L., Heller B.W., Sagebiel R.W., et al. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. Journal of Psychosomatic Research 1985, 29(2):139-153. Available at: http://dx.doi.org/10.1016/0022-3999(85)90035-2 (accessed 30.09.14).
114. Temoshok L.R., Waldstein S.R., Wald R.L., et al. Type C coping, alexithymia, and heart rate reactivity are associated independently and differentially with specific immune mechanisms linked to HIV progression. Brain, Behavior, and Immunity 2008, 22(5):781-792. Available at: http://dx.doi.org/10.1016/j.bbi.2008.02.003 (accessed 30.09.14).
115. Thombs B.D., Bass E.B., Ford D.E., et al. Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine 2006, 21(1):30-38.
116. Thornicroft G. Physical health disparities and mental illness: The scandal of premature mortality. British Journal of Psychiatry 2011, 199(6):441-442.
117. Tully P.J., Cosh S.M. Generalized anxiety disorder prevalence and comorbidity with depression in coronary heart disease: A meta analysis. Journal of Health Psychology 2013, 18(12):1601-1616.
118. Van der Feltz-Cornelis C.M., Nuyen J., Stoop C., et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: A systematic review and meta-analysis. General Hospital Psychiatry 2010, 32(4):380-395.
119. Van Melle J.P., De Jonge P., Spijkerman T.A., et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosomatic Medicine 2004, 66(6):814-822.
120. Vin-Raviv N., Hillyer G.C., Hershman D.L., et al. Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: The BQUAL study. Journal of the National Cancer Institute 2013, 105(8):563-572 10.1093/jnci/djt024.
121. Wahlbeck K., Westman J., Nordentoft M., Gissler M., Laursen T.M. Outcomes of nordic mental health systems: Life expectancy of patients with mental disorders. British Journal of Psychiatry 2011, 199(6):453-458.
122. Watkins L.L., Koch G.G., Sherwood A., et al. Association of anxiety and depression with All-Cause mortality in individuals with coronary heart disease. Journal of the American Heart Association 2013, 2:2.
123. Wulsin L.R., Singal B.M. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine 2003, 65(2):201-210 10.1097/01.PSY.0000058371.50240.E3.
124. Zabora J., BrintzenhofeSzoc K., Curbow B., Hooker C., Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-Oncology 2001, 10(1):19-28.